COCAINE-BASE SMOKING IN RHESUS-MONKEYS - REINFORCING AND PHYSIOLOGICAL-EFFECTS

被引:35
作者
CARROLL, ME [1 ]
KRATTIGER, KL [1 ]
GIESKE, D [1 ]
SADOFF, DA [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,DEPT COMPARAT MED,MINNEAPOLIS,MN 55455
关键词
Cardiovascular effects; Cocaine-base; Monkeys; Self-administration; Smoking;
D O I
10.1007/BF02247123
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Four rhesus monkeys were trained to smoke cocaine-base under a progressive ratio (PR) schedule, with ten smoking trials available each day. Unit dose was varied from 0.25 to 3 mg/kg, and lidocaine (2 mg/kg) was substituted for cocaine. Number of responses and break-point on the PR schedule increased with dose while the number of smoke deliveries increased only slightly. Maximum daily smoke deliveries ranged from six to nine across monkeys. When lidocaine (2 mg/kg) was substituted for cocaine-base, responding decreased to approximately half of that maintained by cocaine, and when cocaine was reinstated, higher response rates returned. Cardiovascular changes associated with cocaine smoking were monitored with an indwelling radio transmitter. There was an initial decrease in heart rate (30 s) followed by a rapid rise and decline by the end of the 15-min trials. Blood pressure increased rapidly after trial onset and returned to pretrial baseline by 15 min. Over the eight trials completed during a session, heart rate and blood pressure steadily increased over presession baselines during the first four trials, but there was then a decline suggesting acute tolerance development. Observations of the monkeys after each trial revealed dilated pupils and slightly agitated, hyperactive behavior. These findings indicated that smoked cocaine-base was rapidly established as a reinforcer for monkeys, and the physiological effects were similar to those reported in studies of human subjects. © 1990 Springer-Verlag.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 29 条
[1]   ACUTE TOLERANCE TO COCAINE IN HUMANS [J].
AMBRE, JJ ;
BELKNAP, SM ;
NELSON, J ;
RUO, TI ;
SHIN, SG ;
ATKINSON, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) :1-8
[2]  
ANDO K, 1981, PSYCHOPHARMACOLOGY, V17, P117
[3]  
[Anonymous], 1968, MERCK INDEX
[4]  
Carroll M E, 1990, Recent Dev Alcohol, V8, P5
[5]   A MICROCOMPUTER SYSTEM FOR THE CONTROL OF BEHAVIORAL-EXPERIMENTS [J].
CARROLL, ME ;
SANTI, PA ;
RUDELL, RL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 14 (03) :415-417
[7]  
Cook CE, 1985, PHARMACOKINETICS PHA, P48
[8]  
Fischman M W, 1984, NIDA Res Monogr, V50, P72
[9]   A COMPARISON OF THE SUBJECTIVE AND CARDIOVASCULAR EFFECTS OF COCAINE AND LIDOCAINE IN HUMANS [J].
FISCHMAN, MW ;
SCHUSTER, CR ;
HATANO, Y .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 18 (01) :123-127
[10]  
FISCHMAN MW, 1976, ARCH GEN PSYCHIAT, V33, P938